GlassScriptPhysician profile
Suzanne L Lekson
NPI 1942242813
$2,383.34
in general payments reported to CMS, 2019-2025
17 companies · $33.44 in 2025
The $33.44 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $386 · 2020: $257 · 2021: $28.81 · 2022: $255 · 2023: $591 · 2024: $833 · 2025: $33.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,457.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $722.93 | 2019-2024 | Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $278.46 | 2020-2023 | Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $252.92 | 2023-2024 | |
| Boston Scientific Corporation | $240.52 | 2019-2020 | |
| Novo Nordisk INC | $176.84 | 2022-2024 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $148.89 | 2023 | Freestyle Libre 3 |
| Exact Sciences Corporation | $118.14 | 2023-2025 | Cologuard Collection Kit |
| Acadia Pharmaceuticals INC | $111.70 | 2024 | Daybue |
| Sanofi Pasteur INC. | $110.90 | 2019 | |
| Dexcom, INC. | $48.56 | 2021-2024 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $46.29 | 2022 | |
| Pfizer INC. | $40.29 | 2019-2022 | |
| Abbvie INC. | $35.23 | 2023 | |
| Idorsia Pharmaceuticals US INC | $14.55 | 2023 | Quviviq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.26 | 2023 | Jardiance |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $13.56 | 2022 | |
| Dynavax Technologies Corporation | $9.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Lekson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.